Allworth Financial’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.2K Buy
1,138
+493
+76% +$8.61K ﹤0.01% 3323
2026
Q1
$12.4K Buy
645
+103
+19% +$2.24K ﹤0.01% 3363
2025
Q4
$11.9K Buy
542
+255
+89% +$4.6K ﹤0.01% 3150
2025
Q3
$3.48K Buy
287
+261
+1,004% +$3.53K ﹤0.01% 3737
2025
Q2
$485 Sell
26
-12
-32% -$238 ﹤0.01% 4143
2025
Q1
$672 Sell
38
-44
-54% -$1.29K ﹤0.01% 3603
2024
Q4
$2.87K Sell
82
-4
-5% -$135 ﹤0.01% 3012
2024
Q3
$3.65K Hold
86
﹤0.01% 2704
2024
Q2
$3.75K Buy
86
+4
+5% +$167 ﹤0.01% 2649
2024
Q1
$2.9K Sell
82
-2
-2% -$54 ﹤0.01% 2655
2023
Q4
$2.48K Buy
84
+4
+5% +$83 ﹤0.01% 2582
2023
Q3
$1.66K Buy
80
+54
+208% +$1.48K ﹤0.01% 2628
2023
Q2
$639 Sell
26
-11
-30% -$354 ﹤0.01% 2843
2023
Q1
$1.5K Buy
37
+2
+6% +$83 ﹤0.01% 2526
2022
Q4
$1.57K Sell
35
-22
-39% -$996 ﹤0.01% 2323
2022
Q3
$3K Buy
57
+45
+375% +$2.47K ﹤0.01% 2068
2022
Q2
$1K Buy
12
+5
+71% +$410 ﹤0.01% 2272
2022
Q1
$1K Buy
+7
New +$817 ﹤0.01% 2027
2021
Q1
Sell
-20
Closed -$2K 1617
2020
Q4
$2K Buy
+20
New +$2.06K ﹤0.01% 1204

Other funds holding TNDM

Allworth Financial's TNDM Position: Q2 2026 in Review

Allworth Financial increased its Tandem Diabetes Care (TNDM) stake by 76% in Q2 2026, buying an estimated $8.61K and bringing the position to 1,138 shares worth $17.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3323.

Allworth Financial first reported a position in TNDM in Q4 2020 and has held it in 19 quarters since. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Allworth Financial held 1,138 shares of Tandem Diabetes Care worth $17.2K as of Q2 2026.
  • Allworth Financial bought 493 Tandem Diabetes Care shares in Q2 2026, an estimated $8.61K.
  • Tandem Diabetes Care made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3323 holding.
  • Allworth Financial first reported a position in Tandem Diabetes Care in Q4 2020 and has held it in 19 quarters since.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.